title: Malaria vaccine research.
abstract: In our report "Activation of Raf as a result of recruitment to the plasma membrane" (3 June, p. 1463) (1), panels E and F of figure 1 on page 1464 were incorrect. The correct photographs appear below. In addition, the [See figure in the PDF file] second sentence of the legend to figure 1 should have read, "The Raf constructs were tagged at the COOH-terminus with a Glu-Glu epitope (MEYMPME) (24) for c-Raf, or at the NH(2)-terminus with both the Glu-Glu and the Myc (MEQKLISEEDL) (23) epitopes for RafCAAX"; the next-to-the-last sentence of the legend to figure 1 should have read, "The c-Raf constructs in (A through D) are Glu-Glu-tagged and were detected by using an anti Glu-Glu antibody, and the RafCAAX and Raf6QCAAX constructs used in E and F were detected by using the antibody to Raf COOH-terminal peptide"; and the third sentence of note 26 should have read, "After blocking with 5% milk in phosphate-buffered saline (M-PBS), cells were incubated with a mouse monoclonal antibody to Glu-Glu or a rabbit polyclonal antibody to a 20-amino acid COOH-terminal peptide of Raf-1 (Santa Cruz Biotechnology, Santa Cruz, California), washed, and incubated with donkey antibodies to mouse or rabbit IgG combined with Texas Red (Jackson) in M-PBS, washed, and mounted in FITC-Guard (Testog)."
authors.forename: W R
authors.initials: WR
authors.lastname: Ballou
authors.forename: C L
authors.initials: CL
authors.lastname: Diggs
authors.forename: S
authors.initials: S
authors.lastname: Landry
authors.forename: B F
authors.initials: BF
authors.lastname: Hall
mesh_terms: D006077:Government Agencies; D006801:Humans; D007391:International Cooperation; D017780:Malaria Vaccines; D009316:National Institutes of Health (U.S.); D012106:Research; D014481:United States; D014944:World Health Organization
chemical_list: D017780:Malaria Vaccines